Yongfeng Xu

2.3k total citations
72 papers, 1.7k citations indexed

About

Yongfeng Xu is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, Yongfeng Xu has authored 72 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Molecular Biology and 14 papers in Neurology. Recurrent topics in Yongfeng Xu's work include Pancreatic and Hepatic Oncology Research (9 papers), Autoimmune Neurological Disorders and Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Yongfeng Xu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (9 papers), Autoimmune Neurological Disorders and Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Yongfeng Xu collaborates with scholars based in China, United States and Taiwan. Yongfeng Xu's co-authors include Jia Fan, Qiang Gao, Yong‐Sheng Xiao, Shuang‐Jian Qiu, Jian Zhou, Yiwei Li, Min‐Jie Ju, Ming‐Yan Cai, Boheng Zhang and Lan Liu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Oncogene.

In The Last Decade

Yongfeng Xu

67 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongfeng Xu China 21 572 488 430 293 192 72 1.7k
Andrew J. Tsung United States 25 706 1.2× 352 0.7× 284 0.7× 495 1.7× 102 0.5× 54 1.5k
Ryota Tamura Japan 22 550 1.0× 340 0.7× 303 0.7× 173 0.6× 163 0.8× 108 1.9k
Christopher L. Tinkle United States 17 702 1.2× 654 1.3× 425 1.0× 496 1.7× 159 0.8× 58 1.9k
Luca Zammataro Italy 18 1.2k 2.0× 665 1.4× 867 2.0× 293 1.0× 144 0.8× 39 2.4k
Daniela Biziato Italy 9 1.2k 2.0× 742 1.5× 876 2.0× 545 1.9× 148 0.8× 11 2.4k
Michael K.K. Wong United States 15 931 1.6× 567 1.2× 553 1.3× 391 1.3× 105 0.5× 25 2.1k
Antonella Zannetti Italy 27 1.1k 1.8× 669 1.4× 240 0.6× 426 1.5× 121 0.6× 66 2.0k
Quang‐Dé Nguyen United Kingdom 25 1.0k 1.8× 642 1.3× 267 0.6× 355 1.2× 142 0.7× 53 2.1k
Shilpa Bhatia United States 20 478 0.8× 706 1.4× 466 1.1× 137 0.5× 161 0.8× 47 1.5k
Daniel H. Madsen Denmark 27 845 1.5× 892 1.8× 650 1.5× 536 1.8× 189 1.0× 60 2.5k

Countries citing papers authored by Yongfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Yongfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongfeng Xu more than expected).

Fields of papers citing papers by Yongfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongfeng Xu. The network helps show where Yongfeng Xu may publish in the future.

Co-authorship network of co-authors of Yongfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongfeng Xu. A scholar is included among the top collaborators of Yongfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongfeng Xu. Yongfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Ying, Meng Yang, Yongfeng Xu, Junhong Han, & Qing Zhu. (2025). Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(4). 189356–189356.
2.
Lai, Qi‐Lun, Meng‐Ting Cai, Guihua Fang, et al.. (2025). Neurofilament light chain levels in neuronal surface antibody-associated autoimmune encephalitis: a systematic review and meta-analysis. Translational Psychiatry. 15(1). 25–25.
3.
Cai, Meng‐Ting, Yi Hua, Qi‐Lun Lai, et al.. (2025). Performance of the 2023 diagnostic criteria for MOGAD: real-world application in a Chinese multicenter cohort of pediatric and adult patients. BMC Medicine. 23(1). 40–40. 1 indexed citations
4.
Chen, Zheng, Mincheng Yu, Bo Zhang, et al.. (2024). SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion. OncoImmunology. 13(1). 2376264–2376264. 3 indexed citations
5.
Jin, Lei, Ju Huang, Lei Guo, et al.. (2023). CYP1B1 promotes colorectal cancer liver metastasis by enhancing the growth of metastatic cancer cells via a fatty acids-dependent manner. Journal of Gastrointestinal Oncology. 14(6). 2448–2465. 6 indexed citations
6.
Xu, Yongfeng, et al.. (2023). The dual role of p63 in cancer. Frontiers in Oncology. 13. 1116061–1116061. 9 indexed citations
7.
Xu, Yongfeng, et al.. (2023). PITX1 plays essential functions in cancer. Frontiers in Oncology. 13. 1253238–1253238. 9 indexed citations
8.
Liang, Qiqiang, Yongfeng Xu, Yu Zhou, et al.. (2022). Severe acute kidney injury predicting model based on transcontinental databases: a single-centre prospective study. BMJ Open. 12(3). e054092–e054092. 10 indexed citations
9.
Cai, Meng‐Ting, Qi‐Lun Lai, Yang Zheng, et al.. (2022). First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency. Multiple Sclerosis and Related Disorders. 66. 104071–104071. 4 indexed citations
10.
11.
Cai, Meng‐Ting, Yang Zheng, Sa Wang, et al.. (2021). Clinical Relevance of Cerebrospinal Fluid Antibody Titers in Anti-N-Methyl-d-Aspartate Receptor Encephalitis. Brain Sciences. 12(1). 4–4. 10 indexed citations
12.
Yang, Yang, Ningna Weng, Junjun Li, et al.. (2021). Identification of Novel Molecular Therapeutic Targets and Their Potential Prognostic Biomarkers Among Kinesin Superfamily of Proteins in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology. 11. 708900–708900. 13 indexed citations
13.
14.
Zhang, Juan, Yongfeng Xu, Lei Wu, Hong‐Fu Li, & Zhi‐Ying Wu. (2020). Characteristic of gut microbiota in southeastern Chinese patients with neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders. 44. 102217–102217. 10 indexed citations
15.
Yan, Jiuliang, Binghai Zhou, Lei Guo, et al.. (2020). GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma.. PubMed. 10(11). 3705–3720. 16 indexed citations
16.
Chen, Sheng, Ni Wang, Xinzhen Yin, et al.. (2017). Clinical features and mutation spectrum in Chinese patients with CADASIL: A multicenter retrospective study. CNS Neuroscience & Therapeutics. 23(9). 707–716. 48 indexed citations
17.
Liu, Lan, Yongfeng Xu, Huang Zhu, & Xiaoyu Wang. (2016). Intravitreal ranibizumab injection combined trabeculectomy versus Ahmed valve surgery in the treatment of neovascular glaucoma: assessment of efficacy and complications. BMC Ophthalmology. 16(1). 65–65. 31 indexed citations
18.
Wan, Ting, Xiuming Jin, Lin Lin, Yongfeng Xu, & Yingying Zhao. (2015). Incomplete Blinking May Attribute to the Development of Meibomian Gland Dysfunction. Current Eye Research. 41(2). 179–185. 50 indexed citations
19.
Cai, Ming‐Yan, Yongfeng Xu, Shuang‐Jian Qiu, et al.. (2009). Human Leukocyte Antigen-G Protein Expression Is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma following Curative Resection. Clinical Cancer Research. 15(14). 4686–4693. 86 indexed citations
20.
Liu, Zhengshan, Cheng Zhang, Yongfeng Xu, et al.. (2008). [Transduction of rhesus bone marrow mesenchymal stem cells by recombinant baculovirus].. PubMed. 48(4). 539–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Tsung Breakdown of academic impact, for papers by Ryota Tamura Breakdown of academic impact, for papers by Christopher L. Tinkle Breakdown of academic impact, for papers by Luca Zammataro Breakdown of academic impact, for papers by Daniela Biziato Breakdown of academic impact, for papers by Michael K.K. Wong Breakdown of academic impact, for papers by Antonella Zannetti Breakdown of academic impact, for papers by Quang‐Dé Nguyen Breakdown of academic impact, for papers by Shilpa Bhatia Breakdown of academic impact, for papers by Daniel H. Madsen
Rankless by CCL
2026